Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABAL.L Regulatory News (ABAL)

  • There is currently no data for ABAL

Trading update

9 Nov 2015 15:57

RNS Number : 0909F
Imaginatik PLC
09 November 2015
Β 

9 November 2015

Imaginatik Plc

Β 

("Imaginatik" or "the Company")

Β 

Trading Update

Β 

Β 

Imaginatik plc (AIM: IMTK.L), the world's first full service innovation provider offering a range of consultancy and technology products, provides a trading update covering the first half of the Company's financial year to 30 September 2015.

Β 

The Company expects to report an increase in recognised revenues of approximately 33% to Β£1.96m (2014: Β£1.47m). This increase combined with the containment of costs will reduce the half year losses to approximately Β£0.41m (2014: Β£0.70m). Particularly encouraging is the increase of approximately 91% in overall bookings in the period to Β£1.97m (2014: Β£1.03m at constant currency). This has been driven primarily by the successful completion of several large multi-year renewals with existing clients. We are pleased to report that we renewed 14 out of the 17 contracts available for renewal and secured 87% of the available renewal revenues in the period.

Β 

In addition, we closed contracts in the period with several new clients including Eli Lilly, Landauer and Alaska Air.

Β 

We are also pleased to report continued progress in the Consulting division, including successfully growing our footprint with several existing customers and expanding the range of our consultancy engagements to include portfolio valuation work, the creation of long term strategy for creating deep innovation capabilities as well as our more traditional consulting support work with our Innovation Central technology platform.

Β 

As we enter the second half of the year, we are currently in contract discussions with a number of other companies and expect to complete several new contracts in the next few weeks. We expect the momentum in the Consulting division to continue, with several new consulting opportunities being developed. There is an equally large number of clients available to renew with us in the second half of the year and we are working diligently to achieve a similar or better result than that achieved in the first half year.

Β 

As stated in previous announcements, as a small company with relatively few high value contracts, the management of cash resources can at times be a challenge. During the period the Company's Chairman, Matt Cooper, advanced the Company $110,000 as a short term loan, of which $50,000 has now been repaid. The balance of this loan together with the balance of the $250,000 loan advanced in January 2015 is scheduled to be repaid over the coming months. The Company will continue to carefully manage its cash reserves and will be considering its various funding options to ensure that the business maintains sufficient levels of investment during this growth phase.

Β 

Matt Cooper, Non-Executive Chairman, commented: "The Board is pleased with the progress Imaginatik is making. The quality of the client base is outstanding for a company of our size and we are seeing pleasing growth in new innovation consulting opportunities."

Β 

Β 

The Company expects to report interim results for the six month period to 30 September 2015 in early December.

Β 

Β 

For further information please contact:

Β 

Imaginatik plc

Tel: 01329 243 243

Matt Cooper Non-Executive Chairman

Ralph Welborn, CEO

Shawn Taylor, CFO

finnCap Ltd

Tel: 020 7220 0500

Jonny Franklin-Adams/Giles Rolls

Daniel Stewart & Company

Tel: 020 7776 6550

Martin Lampshire/David Coffman

Alma PR

Tel: 020 7796 9085

Hilary Buchanan

Β 

About Imaginatik

Β 

Imaginatik provides a range of Innovation solutions comprised of consultancy, enterprise software and program management to deliver innovation results to companies such as The World Bank, The Chubb Group of Insurance Companies, Exxon Mobil, Altria, Shell, Mayo Clinic, Goodyear, the Yorkshire Building Society, Pitney Bowes and Cargill. Few companies possess the internal capability to consistently generate fresh ideas, identify those worth pursuing and reliably transform them into real, value-enhancing assets. Imaginatik's mission is to help these companies build sustainable innovation competencies.

Β 

Imaginatik is a public company whose shares are traded on the AIM market of the London Stock Exchange (LSE:IMTK.L) and is a World Economic Forum Technology Pioneer with offices in Boston, MA, and Fareham, UK. For more information visitΒ www.imaginatik.com.

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTUGGWAGUPAGAB
Date   Source Headline
9th Jun 201710:54 amRNSProposed Placing
27th Apr 20177:00 amRNSChange of Registered Office
25th Apr 20177:00 amRNSTrading Update
24th Apr 20178:16 amRNSHolding(s) in Company
27th Feb 201710:35 amRNSHolding(s) in Company
14th Dec 20169:31 amRNSHolding(s) in Company
9th Dec 201611:47 amRNSHolding(s) in Company
6th Dec 20167:00 amRNSHalf-year Report
25th Nov 20169:56 amRNSHolding(s) in Company
24th Nov 20167:00 amRNSTrading Update and Notice of Results
13th Sep 20162:29 pmRNSResult of AGM
13th Sep 20167:00 amRNSGrant of Options
17th Aug 20167:00 amRNSFinal Results
10th Aug 20163:21 pmRNSHolding(s) in Company
21st Jul 20164:46 pmRNSHolding(s) in Company
28th Jun 201612:12 pmRNSHolding(s) in Company
27th Jun 201611:45 amRNSHolding(s) in Company
24th Jun 20167:00 amRNSResult of Open Offer and Total Voting Rights
16th Jun 201610:35 amRNSHolding(s) in Company
13th Jun 201611:20 amRNSResult of General Meeting
25th May 20167:00 amRNSFundraising
17th May 201612:26 pmRNSFunding Update
17th May 201610:51 amRNSPress Speculation
29th Apr 20169:09 amRNSHolding(s) in Company
28th Apr 201610:54 amRNSHolding(s) in Company
27th Apr 20169:04 amRNSHolding(s) in Company
13th Apr 20161:36 pmRNSHolding(s) in Company
12th Apr 201610:18 amRNSHolding(s) in Company
6th Apr 20164:51 pmRNSHolding(s) in Company
6th Apr 20161:23 pmRNSPress Speculation
9th Mar 20167:00 amRNSTrading Update
26th Jan 201610:03 amRNSHolding(s) in Company
21st Jan 20162:51 pmRNSHolding(s) in Company
5th Jan 20167:00 amRNSDirector Loan
17th Dec 20158:20 amRNSHolding(s) in Company
15th Dec 20157:00 amRNSGrant of Options
10th Dec 20157:00 amRNSHalf Yearly Report
13th Nov 20153:35 pmRNSWarrant Exercise
9th Nov 20153:57 pmRNSTrading update
6th Nov 20154:13 pmRNSHolding(s) in Company
23rd Sep 20153:07 pmRNSResult of AGM
16th Sep 20157:00 amRNSDirector Loan
14th Sep 20155:33 pmRNSHolding(s) in Company
1st Sep 20154:34 pmRNSNotice of AGM
1st Sep 20152:23 pmRNSHolding(s) in Company
24th Aug 20157:00 amRNSHolding(s) in Company
10th Aug 20152:20 pmRNSHolding(s) in Company
6th Aug 20151:41 pmRNSHolding(s) in Company
3rd Aug 201512:05 pmRNSHolding(s) in Company
30th Jul 20151:16 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.